Apyx Medical Corporation
Apyx Medical Corporation (APYX) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
apyx · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Apyx Medical Corporation (APYX) measures how much investors pay for each dollar of the company's trailing earnings. APYX's current PE ratio of N/A is calculated by dividing its stock price of $4.77 by its TTM earnings per share of -$0.22.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2006 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 7 fiscal years · Front-end computedMinQ1 · 25%56.8x
MedianQ3 · 75%1044.5x
Max
At N/A, APYX's current P/E is lower than in 0% of its annual fiscal year readings over the past 7 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Devices · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Apyx Medical CorporationYou APYX | $200M | N/A | — | -$0.22 |
 Atossa Therapeutics, Inc. ATOS | $39M | N/A | — | -$4.04 |
 Lucid Diagnostics Inc. LUCD | $98M | N/A | — | -$0.57 |
 InspireMD, Inc. NSPR | $38M | N/A | — | -$0.66 |
 Pro-Dex, Inc. PDEX | $208M | 15.98x | — | $2.73 |
 Quipt Home Medical Corp. QIPT | $162M | N/A | — | -$0.25 |
 AVITA Medical, Inc. RCEL | $103M | N/A | — | -$1.74 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.27 | — | |
2024-12-31 FY2024 | — | $-0.66 | — | |
2023-12-31 FY2023 | — | $-0.54 | — | |
2022-12-31 FY2022 | — | $-0.67 | — | |
2021-12-31 FY2021 | — | $-0.44 | — | |
2020-12-31 FY2020 | — | $-0.35 | — | |
2019-12-31 FY2019 | — | $-0.58 | — | |
2018-12-31 FY2018 | 3.35x | $1.93 | — | |
2017-12-31 FY2017 | — | $-0.16 | — | |
2016-12-31 FY2016 | — | $-0.14 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Apyx Medical Corporation (APYX) measures how much investors pay for each dollar of the company's trailing earnings. APYX's current PE ratio of N/A is calculated by dividing its stock price of $4.77 by its TTM earnings per share of -$0.22.
Frequently asked questions
APYX pe ratio · 6 questionsAPYX's current PE ratio is N/A as of 2026-06-09, based on a stock price of $4.77 and TTM EPS of -$0.22. Data sourced from Financial Modeling Prep via APYX's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Apyx Medical Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09